These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6172172)

  • 41. Influence of bladder outlet obstruction and detrusor contractility on residual urine in patients with benign prostatic hyperplasia.
    Zhang P; Wu Z; Gao J
    Chin Med J (Engl); 2003 Oct; 116(10):1508-10. PubMed ID: 14570611
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Doppler resistive index in benign prostatic hyperplasia: correlation with ultrasonic appearance of the prostate and infravesical obstruction.
    Kojima M; Ochiai A; Naya Y; Okihara K; Ukimura O; Miki T
    Eur Urol; 2000 Apr; 37(4):436-42. PubMed ID: 10765074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety and efficacy of transurethral needle ablation of the prostate for symptomatic outlet obstruction.
    Rosario DJ; Woo H; Potts KL; Cutinha PE; Hastie KJ; Chapple CR
    Br J Urol; 1997 Oct; 80(4):579-86. PubMed ID: 9352697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Why pressure-flow studies should be optional and not mandatory studies for evaluating men with benign prostatic hyperplasia.
    McConnell JD
    Urology; 1994 Aug; 44(2):156-8. PubMed ID: 7519379
    [No Abstract]   [Full Text] [Related]  

  • 45. [Value of functional examination techniques for the assessment of the clinical aspects of benign prostatic hyperplasia].
    Hohenfellner M; Thüroff JW
    Urologe A; 1992 May; 31(3):142-9. PubMed ID: 1377431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Update evaluation of benign prostatic hyperplasia: when should we offer prostatectomy?
    Cetinel B; Turan T; Talat Z; Yalçin V; Alici B; Solok V
    Br J Urol; 1994 Nov; 74(5):566-71. PubMed ID: 7530119
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Symptomatology and diagnosis of benign prostatic hyperplasia.
    Pavone-Macaluso M
    Eur Urol; 1991; 20 Suppl 1():41-3. PubMed ID: 1722161
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A urodynamic review of bladder outlet obstruction in the male and its clinical implications.
    Warwick RT
    Urol Clin North Am; 1979 Feb; 6(1):171-92. PubMed ID: 86223
    [No Abstract]   [Full Text] [Related]  

  • 49. Urodynamic assessment in the laser treatment of benign prostatic enlargement.
    Te Slaa E; de Wildt MJ; Rosier PF; Wijkstra H; Debruyne FM; de la Rosette JJ
    Br J Urol; 1995 Nov; 76(5):604-10. PubMed ID: 8535680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
    Hamann MF; Naumann CM; Seif C; van der Horst C; Jünemann KP; Braun PM
    Eur Urol; 2008 Oct; 54(4):902-7. PubMed ID: 18502565
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urodynamics after TURP and HoLEP in urodynamically obstructed patients: are there any differences at 1 year of follow-up?
    Rigatti L; Naspro R; Salonia A; Centemero A; Ghezzi M; Guazzoni G; Briganti A; Rigatti P; Montorsi F
    Urology; 2006 Jun; 67(6):1193-8. PubMed ID: 16750253
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detrusor pressure in bladder outlet obstruction.
    Anikwe RM
    Urology; 1978 Aug; 12(2):225-30. PubMed ID: 80872
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Laser prostatectomy: initial experience and urodynamic follow-up.
    Cummings JM; Parra RO; Boullier JA
    Urology; 1995 Mar; 45(3):414-8; discussion 418-20. PubMed ID: 7533453
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urethral closure pressure profiles in the male: an analysis of 280 patients.
    Abrams PH; Torrens MJ
    Urol Int; 1977; 32(2-3):137-45. PubMed ID: 906177
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients.
    Abrams PH; Farrar DJ; Turner-Warwick RT; Whiteside CG; Feneley RC
    J Urol; 1979 May; 121(5):640-2. PubMed ID: 86617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Multifactorial urodynamic study of 115 patients with dysuria and benign prostatic hypertrophy].
    Glémain P; Lenormand L; Buzelin JM; Bertrand D
    Prog Urol; 1992 Jun; 2(3):363-71. PubMed ID: 1284551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detrusor underactivity in men with lower urinary tract symptoms/benign prostatic obstruction: characterization and potential impact on indications for surgical treatment of the prostate.
    Rademakers KL; van Koeveringe GA; Oelke M
    Curr Opin Urol; 2016 Jan; 26(1):3-10. PubMed ID: 26574876
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Challenging the maximum flow rate: a new index of voiding dysfunction in men with benign prostatic enlargement.
    Valentini FA; Nelson PP; Besson GR; Zimmern PE
    BJU Int; 2008 Apr; 101(8):995-9. PubMed ID: 18241248
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Variability of pressure-flow analysis parameters in repeated cystometry in patients with benign prostatic hyperplasia.
    Rosier PF; de la Rosette JJ; Koldewijn EL; Debruyne FM; Wijkstra H
    J Urol; 1995 May; 153(5):1520-5. PubMed ID: 7536260
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Positioning invasive versus noninvasive urodynamics in the assessment of bladder outlet obstruction.
    Arnolds M; Oelke M
    Curr Opin Urol; 2009 Jan; 19(1):55-62. PubMed ID: 19057217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.